Kazia Therapeutics Limited American Depositary Shares (KZIA) is a publicly traded Healthcare sector company. As of May 21, 2026, KZIA trades at $12.96 with a market cap of $143.52M and a P/E ratio of 0.00. KZIA moved +7.41% today. Year to date, KZIA is +126.75%; over the trailing twelve months it is +266.38%. Its 52-week range spans $2.86 to $39.05. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces KZIA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own KZIA include Citadel Advisors and Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Kazia Therapeutics Limited American Depositary Shares.
| Metric | Value |
|---|---|
| Price | $12.96 |
| Market Cap | $143.52M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.05 |
| 52-Week Low | $2.86 |
| Volume | 18 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover KZIA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.